Literature DB >> 9004072

Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports.

S A Chong, C H Tan, H S Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9004072     DOI: 10.1097/00004714-199702000-00024

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review.

Authors:  Christoffer Polcwiartek; Jimmi Nielsen
Journal:  Psychopharmacology (Berl)       Date:  2015-12-02       Impact factor: 4.530

3.  Elevated plasma levels of clozapine after concomitant use of fluvoxamine.

Authors:  M Heeringa; R Beurskens; W Schouten; M M Verduijn
Journal:  Pharm World Sci       Date:  1999-10

Review 4.  The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

Authors:  G MacQueen; L Born; M Steiner
Journal:  CNS Drug Rev       Date:  2001

Review 5.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.